Skip to main content
. 2017 Aug;187(8):1700–1716. doi: 10.1016/j.ajpath.2017.04.009

Figure 3.

Figure 3

Prognostic impact of AKT1/2/3 mRNA expression on overall survival, and progression-free survival rates in patients with diffuse large B-cell lymphoma.

HHS Vulnerability Disclosure